Latest Vaccination Stories
Immunomic Therapeutics, Inc., (ITI), and Bioject have entered into an agreement for ITI to use Bioject’s Biojector®-2000 needle-free injection device with its LAMP™ vaccine platform.
According to the new report from BCC Research, the global market for cancer vaccines is expected to grow to $4.3 billion by 2019, with a five-year compound annual growth rate (CAGR) of 1.3%.
The secret to combating AIDS and the HIV virus could lie in one of the last places you would ever think to look: the immune systems of llamas.
PARIS, December 18, 2014 /PRNewswire/ -- ABIVAX, a leading clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, is pleased
LOS ANGELES, Dec. 17, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
VGXI announces the expansion of its state-of-the-art cGMP manufacturing facility, located in The Woodlands, TX. The Woodlands, TX (PRWEB) December 15, 2014
Amid a growing canine distemper outbreak in Texas, the Texas Veterinary Medical Association urges pet owners to learn about this highly contagious and deadly disease. Austin,
NEW YORK, Dec.
MERIDEN, Conn., Dec.
The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...
- An armed gangster.